
AstraZeneca Agrees to $110 Million Texas Medicaid Settlement
On August 7, 2018, Texas Attorney General Ken Paxton (“Paxton”) announced that the pharmaceutical company AstraZeneca LP (“AstraZeneca”) has agreed to a $110 million settlement to satisfy claims it violated the Texas Medicaid Fraud Prevention Act by falsely marketing its Crestor and Seroquel drugs. AstraZeneca was already under the increased regulations of a corporate integrity […]